Vaginal Dryness, Irritation and Unexpected Bleeding on a GLP-1

The short version

Three things are worth separating before you decide whether any of this needs an appointment.

Dryness and irritation are common during rapid weight loss and are not listed on any GLP-1 label — the plausible mechanisms are indirect, and the direct evidence is thin enough to say so plainly. Itching and discharge are an infection question, and the answer usually lies in a different prescription. Bleeding you did not expect is the one that splits hard by menopausal status: often a returning cycle before menopause, never something to explain away after it.

A boundary, so you land in the right place. This page owns dryness, irritation, cycle changes and bleeding. If your symptoms are itching and discharge — a suspected thrush or urinary infection this week — that has its own page here, UTI or yeast infection on a GLP-1, and its answer is a different prescription in your cabinet rather than anything below.

Everything below is the ten-minute version. Educational only, not medical advice.

What the four labels say: nothing

Reading the current FDA prescribing information for Wegovy, Ozempic, Zepbound and Mounjaro, the words vaginal, vulvovaginal, candidiasis and mycotic appear zero times across all four labels^1,2.

That is a useful fact in one direction and not the other. It means none of this showed up as a drug-attributable adverse reaction in the manufacturers' trials, so nothing here is a known effect of the medication. It does not mean nothing is happening to you. Weight loss itself changes a great deal that no drug label tracks.

Dryness and irritation: the honest position

There is no published evidence that GLP-1 receptor agonists cause vaginal dryness. What exists are two plausible indirect routes, and it is worth knowing which one you might be looking at.

Falling estrogen. Body fat is a source of circulating estrogen after menopause, so losing a lot of it lowers your levels. In a randomized trial of postmenopausal women, a reduced-calorie weight-loss diet cut estradiol by about 16% and free estradiol by about 21%, with larger losses producing larger falls³. Lower estrogen is the standard explanation for vaginal dryness generally. Connecting the two here is reasonable inference, not demonstrated fact — and it points at a treatable problem your clinician deals with routinely.

Fluid losses. The labels do warn about dehydration: diarrhea, nausea and vomiting can cause enough fluid loss to affect the kidneys¹. Anyone that dry systemically is dry everywhere.

And the confounders. Age, perimenopause, hormonal contraception, breastfeeding and antihistamines all cause the same symptom, and starting a GLP-1 does not exempt you from any of them. The medication is often just the most recent change, which makes it the easiest thing to blame.

Practically: a lubricant for symptoms and a vaginal moisturiser for the underlying dryness are the first-line, over-the-counter moves, and persistent dryness is a short and productive conversation with a clinician rather than something to endure for a year.

Itching, discharge and recurrent infections

This is a different problem with a much clearer answer, and it is covered in full in UTI or yeast infection on a GLP-1. The two lines worth repeating here:

Genital fungal infection is not a GLP-1 signal — it is an SGLT2 inhibitor signal, and those drugs (the ones ending in -flozin) carry a dedicated warning for it because they push glucose into the urine. Taking both together is routine in type 2 diabetes, so check your own cabinet before assuming the newest prescription is responsible.

And on recurrence: test rather than guess. The CDC's treatment guidelines set out distinct diagnostic and treatment pathways for bacterial vaginosis and vulvovaginal candidiasis, including specific regimens for recurrent disease⁴. They are different conditions with different treatments, self-diagnosis is unreliable, and a third round of the wrong antifungal is a wasted month.

Bleeding you did not expect

This section splits in two, and the split is the entire point.

Before menopause: often a returning cycle. Weight loss restores ovulation in women whose cycles had become irregular, and the effect is not small. In a randomized trial in women with PCOS, adding semaglutide to metformin produced greater weight loss, higher rates of menstrual cycle recovery, and a natural pregnancy rate of 35% versus 15% over the following six months⁵. Spotting, a cycle arriving after a long absence, or a pattern that suddenly changes can all reflect that. It also means contraception deserves an active decision rather than an assumption — a subject with its own complications, covered in GLP-1s and birth control.

After menopause: always evaluated, never explained away. Vaginal bleeding is the presenting sign in more than 90% of postmenopausal women with endometrial cancer, and ACOG's guidance is that postmenopausal bleeding requires prompt evaluation. Transvaginal ultrasound is usually sufficient as the initial step — an endometrial thickness of 4 mm or less carries a greater than 99% negative predictive value for endometrial cancer — with endometrial sampling a reasonable alternative first approach⁶.

Obesity and type 2 diabetes are both on ACOG's list of clinical risk factors to weigh when evaluating postmenopausal bleeding⁶, which describes a substantial share of people starting these medications. Do not attribute postmenopausal bleeding to weight loss. Book it.

The escalation list

The efficient takeaway

None of this is on the label, which means none of it has been shown to be the drug — and also that nobody has studied most of it. Dryness is plausibly downstream of falling estrogen and fluid loss, and it is treatable. Infections point at a different prescription and deserve a test rather than a guess. And bleeding is the one symptom where your menopausal status changes the answer completely: before menopause it is frequently your body doing what weight loss makes it do, and after menopause it gets evaluated, every time, regardless of what else you have going on.